Estradiol (estradiol gel 0.1%) NDC 70700-144

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-144-35	70700014435	30 PACKET in 1 CARTON (70700-144-35) / .5 g in 1 PACKETMarketed from Oct 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Estradiol
Generic name (nonproprietary): estradiol gel 0.1%
Active ingredients: Estradiol — .5 mg/.5g
Dosage form: Gel
Route: Topical
Labeler: Xiromed, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211783
Marketing start: Oct 1, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Estradiol Congeners (Chemical structure)Estrogen Receptor Agonists (Mechanism)
Identifiers: Product ID 70700-144_5729f205-db48-4ed1-3b2d-190fef4ad81eSPL ID 5729f205-db48-4ed1-3b2d-190fef4ad81eSPL set ID 1a46efe6-21b9-3f0f-90b9-59f279ef51dfRxCUI 2619677, 2619679, 2619681, 2619683, 2619685UNII 4TI98Z838E
Pharmacologic class: Estrogen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470700014435 followed by a unit qualifier and the quantity

Package 70700-0144-35. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 18, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Estradiol gel 0.1% is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause ( 1.1 ). 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211783

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211783
Product	Strength	Form · route	Labeler	Product NDC
Estradiolestradiol gel 0.1%	Estradiol .25 mg/.25g	GelTopical	Xiromed, LLC	70700-143
Estradiolestradiol gel 0.1%	Estradiol 1 mg/g	GelTopical	Xiromed, LLC	70700-145
Estradiolestradiol gel 0.1%	Estradiol .75 mg/.75g	GelTopical	Xiromed, LLC	70700-194
Estradiolestradiol gel 0.1%	Estradiol 1.25 mg/1.25g	GelTopical	Xiromed, LLC	70700-195